UnknownPhase 2NCT01765660

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Studying Chronic graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nanfang Hospital, Southern Medical University
Principal Investigator
Qifa Liu
Nanfang Hospital, Southern Medical University
Intervention
Mesenchymal stem cells(biological)
Enrollment
60 enrolled
Eligibility
12-65 years · All sexes
Timeline
2013 – 2016

Study locations (1)

Collaborators

Sun Yat-sen University · Peking University People's Hospital · Guangdong Provincial People's Hospital · Guangzhou General Hospital of Guangzhou Military Command · Southern Medical University, China · Third Affiliated Hospital, Sun Yat-Sen University · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou First People's Hospital · Zhongshan People's Hospital, Guangdong, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01765660 on ClinicalTrials.gov

Other trials for Chronic graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Chronic graft versus host disease →

← Back to all trials